GOP ones are to obesity, what eyeglasses are to nearsightedness.

Where are the reusable rockets for biotech?

Traditional drug development is painstakingly time consuming risky and expensive.

One molecule has no bearing on the next molecule that gets developed.

Like traditional rockets, their one time you sold me.

That's changing.

Now as these models begin to be deployed in real world situations, the big question is why? Why do these models say the things they do? Why do some prompts produce better results than others? And perhaps most importantly,

how do we control what they do?

Lots of companies are potentially

going to go bankrupt if they have to pay for these drugs,

if they have even one employee

who ends up being eligible for one of these therapies.

And so I do think there is a siren call already from the industry

that will sort of ignite a cycle of innovation.

In a lot of ways, these new programmable medicines are just a fundamentally new

superpower. Smart energy grits, programmable medicines, voice first companion apps, and crime detecting

computer vision.

We asked our investment partners across A16Z to preview one big idea that they believe will spur innovation in 2024.

Now our team compiled a list of 40-plus

builder-worthy pursuits for the coming year that you can now find at A16Z.com

slash Big Ideas 2024.

Or you can click the link in our description.

...